- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Col1a2-CreERT2 Mouse Model
| Strain Name | C57BL/6NMcl-Col1a2<sup>tm1(P2A-CreERT2)</sup>/MCL |
|---|---|
| Editing Type | Knock-In |
| Catalog No. | M02086 |
| Strain Background | C57BL/6NMcl |
| Gene Name | Col1a2/collagen type I alpha 2 chain |
| Gene Synonyms | Cola2、Cola-2、Col1a-2 |
| NCBI No. | 12843 / MGI: 88468 |
| Preserving Method | Live or Cryopreserved |
- Fibroblast- and Mesenchymal-Cell-Specific Gene Knockout or Activation
- Fibroblast Lineage Tracing and Fate Mapping Research
- Research on Pulmonary, Hepatic, Renal, Cardiac, and Dermal Fibrosis
- Studies on Extracellular Matrix Deposition and Collagen Metabolism
- Research on Tissue Injury Repair, Wound Healing, and Regeneration
- Studies on Cancer-Associated Fibroblasts and the Tumor Microenvironment
- Research on Cardiovascular Remodeling and Perivascular Stromal Cells
- Studies on Bone, Cartilage, and Connective Tissue Diseases
- Doronina VA, et al. Site-specific release of nascent chains from ribosomes at a sense codon. Mol Cell Biol. 2008;28:4227–4239.
- Zheng B, et al. Ligand-dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am J Pathol. 2002;160:1609–1617.
- He L, et al. Preexisting endothelial cells mediate cardiac neovascularization after injury. J Clin Invest. 2017;127:2968–2981.
- Feil R, et al. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun. 1997;237:752–757.
- Col1a2-Expressing Cell Targeting: Driven by the endogenous Col1a2 promoter, Cre_ERT2_ expression targets fibroblasts and other mesenchymal cells expressing type I collagen, making it suitable for stromal cell studies across various tissues.
- Endogenous Expression Synchronization: Utilizing a P2A element allows Col1a2 and CreERT2 to be translated from the same transcript, ensuring that the spatiotemporal expression pattern of CreERT2 closely matches that of endogenous Col1a2.
- Inducible Spatiotemporal Control: CreERT2 requires tamoxifen induction to enter the nucleus and mediate LoxP site recombination. By regulating the timing and dosage of administration, gene knockout, activation, or cell labeling can be initiated at specific developmental stages or disease stages.
- Reduction of Unintended Developmental Recombination: Compared to constitutive Col1a2-Cre, the tamoxifen-inducible system minimizes permanent recombination caused by transient embryonic Col1a2 expression, making it better suited for studies involving adult mouse fibroblasts and mesenchymal cells.
- Preservation of Col1a2 Function: The P2A-CreERT2 cassette is inserted prior to the stop codon without replacing the main coding sequence of Col1a2, maintaining the expression and function of the endogenous type I collagen $\alpha2$ chain as much as possible while expressing CreERT2.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.

